Celero Systems, Inc.

BROOKLINE, MA · Founded 2017 · Digital health · Private

Software platform for monitoring, diagnosing, and treating life-threatening conditions

Claim this profile

Follows are private to you and power your alerts

Updated · celerosystems.com

Sector
Digital health
Headquarters
BROOKLINE, MA
Founded
2017
Latest Form D
$3M, Jul 2019
Total capital
$3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$3M
1 Form D · last Jul 2019
88 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
17 pending · first 2023
Rank in peer group#27 of 312

Capital timeline

2019FEDERAL ↑EQUITY ↓Cumulative $3M1st Form D$3M
2019FEDERAL ↑EQUITY ↓Cumulative $3M1st Form D$3M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 312 peers

Line = median

Digital health · Platform

  • Granted patents#27 · top 9%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Benjamin PlessResearcherExecutive Officer, DirectorLinked by 2 patents
  • Allan Giovanni MayDirectorNamed in SEC Form D filings
  • Carlo Giovanni TraversoDirectorNamed in SEC Form D filings
  • Xin Giovanni HuangDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 19
  • PendingGastric Residency System For Electronic Ingestible DevicesUSPTOApplication 18854165
  • PendingOpioid Overdose Rescue DeviceUSPTOApplication 18783724
  • GrantedOpioid Overdose Rescue DeviceUSPTOUS 12,053,606
Show all 19 patent records
  • Gastric Residency System For Electronic Ingestible DevicesDec 4, 2025 · Application 18854165Pending
  • Opioid Overdose Rescue DeviceDec 5, 2024 · Application 18783724Pending
  • Opioid Overdose Rescue DeviceAug 6, 2024 · US 12,053,606Granted
  • Ingestible Anxiety Monitoring And Treatment SystemMay 9, 2024 · Application 18549953Pending
  • Intestinal Attachment DeviceOct 24, 2023 · US 11,793,980Granted
  • Ingestible Medical DeviceFeb 23, 2023 · Application 17795420Pending
  • Gastrointestinal Suture Retention SystemOct 6, 2022 · Application 17709516Pending
  • Integrated Physiological Monitoring And Tissue Anchoring DeviceOct 6, 2022 · Application 17705431Pending
  • Swallowable Device For Sleep Apnea DetectionJun 23, 2022 · Application 17553970Pending
  • Ingestible Electronically Triggered Drug Delivery SystemApplication 63451718Pending
  • Ingestible Electronically Triggered Drug Delivery SystemApplication 19139554Pending
  • Ingestible Anxiety Monitoring And Treatment SystemApplication PCTUS2022020112Pending
  • Ingestible Medical DeviceApplication PCTUS2021015224Pending
  • Intestinal Attachment DeviceApplication PCTUS2020065823Pending
  • Gastric Residency System For Electronic Ingestible DevicesApplication PCTUS2023065313Pending
  • Ingestible Electronically Triggered Drug Delivery SystemApplication PCTUS2023085026Pending
  • Opioid Overdose Rescue DeviceApplication PCTUS2020048685Pending
  • Gastric Residency System For Electronic Ingestible DevicesApplication 63327108Pending
  • Ingestible Suture Cutting MechanismApplication 63326935Pending

Regulatory activity · Digital health

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .